Veklury Adverse Reactions

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Contraindications Warnings Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

The information highlighted (if any) are the most recent updates for this brand.

Full Prescribing Info

Adverse Reactions

The following adverse reactions may occur. Patients should be carefully monitored and if any abnormalities are observed, appropriate measures such as discontinuing administration of VEKLURY should be taken.
Clinically Significant Adverse Reactions: Hepatic Impairment: If the signs or symptoms of hepatic impairment or laboratory abnormalities (abnormality of conjugated bilirubin, ALP or INR) are observed in addition to ALT elevations, treatment should be discontinued. [See Important Precautions and Patients with Hepatic Impairment under Precautions.]
Hypersensitivity (Including infusion reactions and anaphylactic reactions): Hypotension, hypertension, tachycardia, bradycardia, hypoxia, fever, dyspnea, wheezing, angioedema, rash, nausea, vomiting, diaphoresis, and shivering, etc. may occur. [See Important Precautions under Precautions.]
Other adverse reactions: See Table 11.

Click on icon to see table/diagram/image

View ADR Reporting Link

remdesivir

Manufacturer:

Gilead Sciences

Distributor:

DCH Auriga - Healthcare

Four Star